Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

OCTOBER 1, 2021

CannEpil, a cannabis-based oral solution intended for drug-resistant epilepsy, is due to be accessible from mid-October as part of the Health Service Executive’s (HSE) Medicinal Cannabis Access Programme (MCAP). For us clinicians looking after patients with epilepsy the evidence base is for pure CBD products,” he told the committee.

Medicine 52

Medicine Epilepsy Legalization Patients 52

MMJ Recs

DECEMBER 17, 2023

Here’s some insight into what the program involves: Intractable Epilepsy Focus: The TCUP is highly focused, primarily catering to individuals diagnosed with one of a specific number of qualifying conditions (more on this below). These dispensaries operate under strict regulations to ensure compliance with the TCUP guidelines.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

OCTOBER 8, 2021

In particular, now the attention of the motion is turned to epilepsy. “ Sicily can offer itself as the leading region for estimating medical cannabis needs, ” said Angela Foti, vice president of Ars and regional deputy of Attiva Sicilia. “Epilepsy is one of the most frequent neurological diseases,” the report reads. “30%

Epilepsy 52

Epilepsy Chronic Pain Patients Treatment 52

Cannabis Law Report

JANUARY 13, 2020

Epidyolex became available for British epilepsy sufferers from January 6 after the government approved it for NHS use, along with mouth spray while Sativex, which contains CBD and THC and is used to treat multiple sclerosis. percent of UK citizens suffering from epilepsy use cannabis to self-medicate, and about 19.23

Epilepsy 59

Epilepsy Medicine Conditions Patients 59

MMJ Recs

DECEMBER 13, 2023

However, the tide began to turn in 2015 when the state legislature passed the Compassionate Use Act, allowing for the limited use of low-THC cannabis for patients with intractable epilepsy. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

MMJ Recs

JUNE 3, 2024

Eligibility hinges on qualifying conditions, ranging from chronic pain to epilepsy. Guardians or parents can apply on behalf of minors in need of treatment. Physician Recommendation If the physician believes that medical marijuana is a suitable treatment for your condition, they will provide you with a written recommendation.

Programs 52

Programs Marijuana Patients Chronic Pain 52

MMJ Recs

APRIL 11, 2024

West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. Patients must obtain a written certification from a registered physician confirming their diagnosis and recommending medical marijuana as a treatment option.

Law 52

Law Programs Patients Conditions 52

MMJ Recs

MARCH 12, 2024

The Compassionate Use Act (CUA) permits the use of low-THC cannabis oil for patients with certain qualifying conditions, such as epilepsy and multiple sclerosis. However, they must also be aware of potential discrimination issues and ensure compliance with state and federal anti-discrimination laws.

Law 52

Law Compliance Compliance Policy 52

MMJ Recs

JANUARY 15, 2024

To ensure compliance, the CRC regularly updates and refines the program’s guidelines, so be sure to check the NJ.gov website for the most up-to-date info. Research has demonstrated the effectiveness of medical marijuana in treating conditions like multiple sclerosis, epilepsy , and certain cancer-related symptoms.

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

MMJ Recs

FEBRUARY 16, 2024

Its implementation reflects a measured step towards compassionate healthcare, providing eligible patients with access to alternative treatments that have shown promise in alleviating symptoms and improving their overall quality of life.

Legalization 52

Legalization Marijuana Dispensary Conditions 52

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. During the appointment, the physician will review the patient’s medical history and assess whether medical marijuana is a suitable treatment option.

Access 52

Access Marijuana Patients Programs 52

Cannabis Law Report

JULY 28, 2021

Despite a thriving market, CBD is only approved for use by the FDA in very few scenarios, including for the treatment of epilepsy through a drug called Epidiolex. Skin health or acne treatment. Grand View Research reported that the global cannabidiol market was valued at $2.8 from 2021 to 2028. Limited Research. For my pet.

CBD 75

CBD Food Treatment Conditions 75

Veriheal

SEPTEMBER 22, 2020

Only patients suffering from specific conditions, namely cancer, epilepsy, muscle spasms, and chronic seizures, were given permission to use cannabis as treatment. The 2016 law also established more Medical Marijuana Treatment Centers, making it easier for patients to access cannabis.

Edibles 52

Edibles Patients Chronic Pain Conditions 52

Cannabis Law Report

MARCH 25, 2019

The UK’s first specialist medicinal cannabis centre opened earlier this month, charging £200 ($264) per appointment, and between £600 ($792) and £700 ($925) per month for treatment. This clinic will represent a lifeline to those who have found other treatments ineffective.

Chronic Pain 45

Chronic Pain Epilepsy Medicine Treatment 45

MMJ Recs

APRIL 3, 2024

The Ohio Medical Marijuana Control Program (OMMCP) oversees the implementation and regulation of the state’s medical cannabis industry, ensuring compliance with legal requirements and standards for cultivation, processing, testing, and distribution. Featured image by 12019 on Pixabay.

Law 52

Law Marijuana Conditions Patients 52

PrestoDoctor

AUGUST 2, 2023

In the state of Iowa, obtaining a medical cannabis card is a pathway towards accessing this alternative form of treatment legally and safely. Conditions include chronic pain, epilepsy, multiple sclerosis, cancer, and post-traumatic stress disorder (PTSD). The benefits of medical cannabis are vast and diverse.

Conditions 52

Conditions Epilepsy Dispensary Patients 52

MMJ Recs

FEBRUARY 3, 2024

Understanding these regulations is crucial for patients, caregivers, and dispensaries alike to ensure compliance with the law. In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment.

Legislation 52

Legislation Law Marijuana Dispensary 52

MMJ Recs

JULY 1, 2024

For those seeking access to medical cannabis, obtaining an MMJ (Medical Marijuana) card is the first step toward obtaining this alternative treatment. Here’s a list for a patient to qualify: Cancer, if the underlying condition or treatment produces severe or chronic pain, nausea or severe vomiting, cachexia, or severe wasting.

Marijuana 52

Marijuana Chronic Pain Treatment Programs 52

MMJ Recs

MARCH 14, 2024

These conditions include, but are not limited to, cancer, epilepsy, multiple sclerosis, and PTSD, among others. Additionally, individuals experiencing severe pain, nausea, or muscle spasms are eligible for medical marijuana treatment.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

MARCH 21, 2019

Only CBD products produced in compliance with the Farm Bill would be legal by federal law. In order to legally posses CBD in Alabama , you must be in accordance to Leni’s Law which states you must be diagnosed with a debilitating medical condition and be undergoing treatment or you are part of a state-sponsored clinical trial.

State Laws 55

State Laws Law CBD Legalization 55

MMJ Recs

APRIL 19, 2024

Qualifying conditions for medical marijuana use include chronic pain, epilepsy, multiple sclerosis, cancer, and terminal illnesses. Licensed cultivators, processors, and dispensaries must adhere to stringent guidelines to ensure compliance with state regulations and maintain the integrity of the medical marijuana program.

Law 52

Law Marijuana Access History 52

Cannabis Law Report

DECEMBER 14, 2019

VANCOUVER, British Columbia, Dec. 12, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) ( PU31.F Prohibition Partners estimates that there are as many as 3.6 million active cannabis users in the UK.

Pharmaceutical 45

Pharmaceutical Chronic Pain Patients Epilepsy 45

Cannabis Law Report

FEBRUARY 15, 2019

Grow Biotech’s team of specialists worked alongside doctors to address their concerns regarding quality assurance and compliance for the prescriptions they have written, bridging the gap between existing cannabis medicines and accepted pharmaceutical standards. And even then they risked having it seized at customs.

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

JUNE 1, 2021

Over the course of her career, she has established, developed, and led several key areas of human resource functions including communications and strategy, talent engagement and management, compliance, and mergers and acquisitions. Company remains on track for potential approval of Vicineum™ in the US in August 2021. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

Cannabis Law Report

MAY 17, 2019

First, despite prohibiting food, drugs and cosmetics products deemed to be “adulterated” or “misbranded” or making “false or unsubstantiated” health claims, the FDA provides zero guidance on how to comply either with current FDA regulations or those to be promulgated in compliance with Farm Bill.

Food 10

Food DEA Hemp CBD 10

WeedAdvisor

JUNE 27, 2019

Instead, it was the work of a group of desperate families, mainly mothers, producing cannabis for seriously ill relatives, an often highly successful treatment option that was strictly prohibited by Peruvian law.”. Her 19-year-old son, Anthony, suffers from Lennox-Gastaut syndrome, a rare form of severe childhood epilepsy.

Marijuana 45

Marijuana Media Cultivation Epilepsy 45

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 45

Research and Development CBD Conditions Therapy 45

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. A: Qualifying medical conditions in Ohio include cancer, PTSD, chronic pain, epilepsy, and more. Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety.

Dispensary 52

Dispensary Patients Marijuana Education 52

PrestoDoctor

JANUARY 15, 2024

Some of the qualifying conditions include multiple sclerosis, post-traumatic stress disorder (PTSD), and epilepsy. These conditions are recognized by the West Virginia Medical Cannabis Act as suitable for medical cannabis treatment. However, this is not an exhaustive list.

Marijuana 52

Marijuana Conditions Access Patients 52

Cannabis Law Report

JUNE 14, 2019

Zachary Kobrin has served as General Counsel & Chief Compliance Officer for a multinational cannabis company and Florida MMTC and currently advises cannabis and hemp industry clients on legal, regulatory, and business development issues.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

FEBRUARY 4, 2019

The Rohrbacher-Farr amendment creates a limited exception, preventing the DOJ from prosecuting anyone in strict compliance with state medical marijuana laws (adult-use or recreational uses of CBD products may still be prosecuted). CBD products with THC content above 0.3%

Hemp 40

Hemp CBD Legalization Food 40

MMJ Recs

JANUARY 6, 2024

Each type of MMJ product caters to different preferences, medical conditions, and lifestyle choices, ensuring that patients have diverse options for incorporating medical marijuana into their treatment plans. We’ll now take a look at some of the most popular options, how they’re used, and which conditions they may be effective in treating.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Cannabis Law Report

JUNE 26, 2019

Kobrin has served as General Counsel & Chief Compliance Officer for a multinational cannabis company and Florida MMTC and currently advises cannabis and hemp industry clients on legal, regulatory and business development issues. Zachary Kobrin. Cameron Vance, Ph.D. Sally Kent Peebles. Jacel Delgadillo. Eric Stevens.

Marijuana 65

Marijuana Agriculture Research and Development Education 65